TOMM40L
geneOn this page
Also known as FLJ12770TOMM40B
Summary
TOMM40L (translocase of outer mitochondrial membrane 40 like, HGNC:25756) is a protein-coding gene on chromosome 1q23.3, encoding Mitochondrial import receptor subunit TOM40B (Q969M1). Potential channel-forming protein implicated in import of protein precursors into mitochondria.
Predicted to enable protein transmembrane transporter activity. Predicted to be involved in protein import into mitochondrial matrix. Located in mitochondrion. Part of protein-containing complex.
Source: NCBI Gene 84134 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_032174
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25756 |
| Approved symbol | TOMM40L |
| Name | translocase of outer mitochondrial membrane 40 like |
| Location | 1q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ12770, TOMM40B |
| Ensembl gene | ENSG00000158882 |
| Ensembl biotype | protein_coding |
| Entrez | 84134 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 11 protein_coding, 6 protein_coding_CDS_not_defined
ENST00000367987, ENST00000367988, ENST00000465512, ENST00000468803, ENST00000470426, ENST00000474486, ENST00000475793, ENST00000492482, ENST00000545897, ENST00000904816, ENST00000904817, ENST00000904818, ENST00000904819, ENST00000904820, ENST00000911458, ENST00000951901, ENST00000951902
RefSeq mRNA: 3 — MANE Select: NM_032174
NM_001286373, NM_001286374, NM_032174
CCDS: CCDS1227, CCDS65700
Canonical transcript exons
ENST00000367988 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001205354 | 161226060 | 161226136 |
| ENSE00001845974 | 161228956 | 161230746 |
| ENSE00003482445 | 161228715 | 161228817 |
| ENSE00003498713 | 161228428 | 161228504 |
| ENSE00003500977 | 161228186 | 161228308 |
| ENSE00003583099 | 161227258 | 161227350 |
| ENSE00003624253 | 161226888 | 161226955 |
| ENSE00003633255 | 161227636 | 161227737 |
| ENSE00003649346 | 161226355 | 161226604 |
| ENSE00003663480 | 161227884 | 161227989 |
Expression profiles
Bgee: expression breadth ubiquitous, 224 present calls, max score 92.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.2520 / max 99.5005, expressed in 1656 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 6239 | 5.8681 | 1636 |
| 6238 | 0.3839 | 191 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 92.97 | gold quality |
| apex of heart | UBERON:0002098 | 91.77 | gold quality |
| right lobe of liver | UBERON:0001114 | 91.28 | gold quality |
| heart left ventricle | UBERON:0002084 | 89.57 | gold quality |
| cardiac ventricle | UBERON:0002082 | 89.33 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.99 | gold quality |
| right atrium auricular region | UBERON:0006631 | 88.53 | gold quality |
| cardiac atrium | UBERON:0002081 | 88.20 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.98 | gold quality |
| heart | UBERON:0000948 | 87.65 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.34 | gold quality |
| myocardium | UBERON:0002349 | 87.17 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 87.05 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.98 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.73 | gold quality |
| cortical plate | UBERON:0005343 | 86.69 | gold quality |
| muscle of leg | UBERON:0001383 | 86.64 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.58 | gold quality |
| frontal cortex | UBERON:0001870 | 86.44 | gold quality |
| neocortex | UBERON:0001950 | 86.28 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.03 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.74 | gold quality |
| vastus lateralis | UBERON:0001379 | 85.08 | silver quality |
| cerebral cortex | UBERON:0000956 | 84.77 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 84.74 | gold quality |
| heart right ventricle | UBERON:0002080 | 84.69 | gold quality |
| bone marrow cell | CL:0002092 | 84.57 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 84.48 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 84.17 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.65 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting TOMM40L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-623 | 99.76 | 68.16 | 1170 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-106A-3P | 99.53 | 67.58 | 995 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-4777-3P | 99.15 | 68.92 | 626 |
| HSA-MIR-4324 | 99.04 | 70.14 | 1569 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-2355-5P | 98.83 | 65.51 | 1589 |
Literature-anchored findings (GeneRIF, showing 1)
- APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer’s Disease. (PMID:33016906)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tomm40l | ENSMUSG00000005674 |
| rattus_norvegicus | Tomm40l | ENSRNOG00000003398 |
| drosophila_melanogaster | Tom40 | FBGN0016041 |
| drosophila_melanogaster | tomboy40 | FBGN0033074 |
| caenorhabditis_elegans | WBGENE00007686 |
Paralogs (1): TOMM40 (ENSG00000130204)
Protein
Protein identifiers
Mitochondrial import receptor subunit TOM40B — Q969M1 (reviewed: Q969M1)
Alternative names: Protein TOMM40-like
All UniProt accessions (1): Q969M1
UniProt curated annotations — full annotation on UniProt →
Function. Potential channel-forming protein implicated in import of protein precursors into mitochondria.
Subunit / interactions. Forms part of the preprotein translocase of the outer mitochondrial membrane (TOM complex) containing TOMM22, TOMM40, TOMM40L and TOMM70. Interacts with mitochondrial targeting sequences.
Subcellular location. Mitochondrion outer membrane.
Similarity. Belongs to the Tom40 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q969M1-1 | 1 | yes |
| Q969M1-2 | 2 |
RefSeq proteins (3): NP_001273302, NP_001273303, NP_115550* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR023614 | Porin_dom_sf | Homologous_superfamily |
| IPR027246 | Porin_Euk/Tom40 | Family |
| IPR037930 | Tom40 | Family |
Pfam: PF01459
UniProt features (5 total): region of interest 2, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969M1-F1 | 90.39 | 0.80 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 129 (showing top):
GGGNRMNNYCAT_UNKNOWN, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GGGTGGRR_PAX4_03, YY1_Q6, GGCNKCCATNK_UNKNOWN, CCANNAGRKGGC_UNKNOWN, YY1_02, TCF11_01, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, GGCNNMSMYNTTG_UNKNOWN, GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX
GO Biological Process (5): monoatomic ion transport (GO:0006811), protein import into mitochondrial matrix (GO:0030150), biological_process (GO:0008150), protein transport (GO:0015031), transmembrane transport (GO:0055085)
GO Molecular Function (3): transmembrane protein transporter activity (GO:0008320), porin activity (GO:0015288), molecular_function (GO:0003674)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial outer membrane translocase complex (GO:0005742), protein-containing complex (GO:0032991), pore complex (GO:0046930), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 3 |
| protein transmembrane import into intracellular organelle | 1 |
| protein localization to mitochondrion | 1 |
| import into the mitochondrion | 1 |
| mitochondrial protein import pathway | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| cellular process | 1 |
| macromolecule transmembrane transporter activity | 1 |
| protein transmembrane transport | 1 |
| protein transporter activity | 1 |
| wide pore channel activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| outer mitochondrial membrane protein complex | 1 |
| cellular_component | 1 |
| membrane protein complex | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1304 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TOMM40L | TOMM22 | Q9NS69 | 736 |
| TOMM40L | TOMM5 | Q8N4H5 | 576 |
| TOMM40L | TOMM7 | Q9P0U1 | 568 |
| TOMM40L | NDUFS2 | O75306 | 535 |
| TOMM40L | TOMM70 | O94826 | 518 |
| TOMM40L | TIMM10 | P62072 | 502 |
| TOMM40L | TIMM9 | Q9Y5J7 | 501 |
| TOMM40L | TIMM8B | Q9Y5J9 | 477 |
| TOMM40L | TIMM44 | O43615 | 473 |
| TOMM40L | TIMM23 | O14925 | 473 |
| TOMM40L | SAMM50 | Q9Y512 | 458 |
| TOMM40L | TIMM22 | Q9Y584 | 440 |
| TOMM40L | ZC3H8 | Q8N5P1 | 439 |
| TOMM40L | TIMM13 | P62206 | 434 |
| TOMM40L | TIMM50 | Q3ZCQ8 | 434 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TOMM22 | TOMM40 | psi-mi:“MI:0914”(association) | 0.740 |
| TOMM22 | XRCC3 | psi-mi:“MI:0914”(association) | 0.640 |
| TOMM40L | RAB1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| TOMM6 | TOMM40 | psi-mi:“MI:0914”(association) | 0.350 |
| TOMM7 | AMY2A | psi-mi:“MI:0914”(association) | 0.350 |
| MTCH2 | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (11): TOMM40L (Affinity Capture-RNA), TOMM40L (Affinity Capture-RNA), TOMM40L (Affinity Capture-RNA), AFMID (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Affinity Capture-MS), TOMM40L (Two-hybrid)
ESM2 similar proteins: A0A1S4A695, A0A6P7EFR0, A4F267, A6QR22, O97556, P07144, P21796, P42055, P42056, P45879, P45880, P50395, P50397, P50399, P62495, P62496, P62497, P62498, P68002, P68003, P81004, P81155, P82013, P86223, Q0VCK5, Q0VCX5, Q1W374, Q1W375, Q1W376, Q1W377, Q29380, Q5R4C7, Q5R7V4, Q5RCE1, Q5U2Q7, Q60930, Q60931, Q60932, Q61598, Q6Q7J2
Diamond homologs: A1Z6L1, A4F267, A6QR22, O96008, Q18090, Q1LZB5, Q61Z83, Q6P825, Q75Q40, Q7ZTM6, Q969M1, Q9CZR3, Q9QYA2, Q9U4L6, Q9LHE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2083 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:161226133:GATG:G | donor_gain | 1.0000 |
| 1:161226474:A:AG | acceptor_gain | 1.0000 |
| 1:161226475:G:GG | acceptor_gain | 1.0000 |
| 1:161226601:AAAGG:A | donor_loss | 1.0000 |
| 1:161226602:AAGG:A | donor_loss | 1.0000 |
| 1:161226603:AGGTG:A | donor_loss | 1.0000 |
| 1:161226604:GGTGA:G | donor_loss | 1.0000 |
| 1:161226605:G:C | donor_loss | 1.0000 |
| 1:161227721:C:G | donor_gain | 1.0000 |
| 1:161227982:G:GT | donor_gain | 1.0000 |
| 1:161228182:ACAGT:A | acceptor_gain | 1.0000 |
| 1:161228183:CA:C | acceptor_loss | 1.0000 |
| 1:161228184:A:AG | acceptor_gain | 1.0000 |
| 1:161228184:AGT:A | acceptor_gain | 1.0000 |
| 1:161228185:G:GT | acceptor_gain | 1.0000 |
| 1:161228185:GT:G | acceptor_gain | 1.0000 |
| 1:161228185:GTG:G | acceptor_gain | 1.0000 |
| 1:161228185:GTGA:G | acceptor_gain | 1.0000 |
| 1:161228185:GTGAT:G | acceptor_gain | 1.0000 |
| 1:161228275:G:GT | donor_gain | 1.0000 |
| 1:161228298:G:GT | donor_gain | 1.0000 |
| 1:161228298:G:T | donor_gain | 1.0000 |
| 1:161228301:G:GG | donor_gain | 1.0000 |
| 1:161228306:CGG:C | donor_loss | 1.0000 |
| 1:161228307:GG:G | donor_gain | 1.0000 |
| 1:161228308:GG:G | donor_gain | 1.0000 |
| 1:161228309:G:C | donor_loss | 1.0000 |
| 1:161228310:T:A | donor_loss | 1.0000 |
| 1:161228323:G:GT | donor_gain | 1.0000 |
| 1:161228426:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
2001 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:161228778:T:G | Y250D | 0.998 |
| 1:161228478:A:C | S220R | 0.997 |
| 1:161228480:T:A | S220R | 0.997 |
| 1:161228480:T:G | S220R | 0.997 |
| 1:161228481:T:G | Y221D | 0.997 |
| 1:161228207:T:C | L169P | 0.996 |
| 1:161228237:G:A | G179E | 0.996 |
| 1:161228236:G:A | G179R | 0.995 |
| 1:161228236:G:C | G179R | 0.995 |
| 1:161228294:C:A | A198D | 0.995 |
| 1:161228249:T:A | V183D | 0.994 |
| 1:161228776:G:A | G249D | 0.993 |
| 1:161228251:T:G | Y184D | 0.992 |
| 1:161228817:G:C | G263R | 0.992 |
| 1:161227684:G:C | A109P | 0.991 |
| 1:161228458:G:A | G213E | 0.991 |
| 1:161228475:G:C | A219P | 0.991 |
| 1:161228722:T:A | V231D | 0.991 |
| 1:161228725:G:A | G232E | 0.991 |
| 1:161227947:G:C | A148P | 0.990 |
| 1:161228237:G:T | G179V | 0.990 |
| 1:161228246:T:C | L182P | 0.990 |
| 1:161228302:T:G | Y201D | 0.990 |
| 1:161228739:G:C | A237P | 0.990 |
| 1:161228778:T:A | Y250N | 0.990 |
| 1:161228956:G:A | G263D | 0.990 |
| 1:161226569:C:A | P27H | 0.989 |
| 1:161226602:A:T | K38I | 0.989 |
| 1:161227945:C:A | T147K | 0.989 |
| 1:161228476:C:A | A219E | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000743440 (1:161230686 A>G), RS1000935000 (1:161228070 T>C), RS1002294447 (1:161227015 T>C), RS1002296489 (1:161226268 T>A,C,G), RS1002363263 (1:161227478 TGAGA>T,TGA), RS1002514058 (1:161225225 C>T), RS1003036836 (1:161224895 C>T), RS1003296079 (1:161228885 G>A,C), RS1004390814 (1:161230489 A>G), RS1004444571 (1:161230224 C>T), RS1004780405 (1:161228695 T>C), RS1004851301 (1:161225179 T>C), RS1006446654 (1:161227752 T>C), RS1006828059 (1:161226095 G>A), RS1008782647 (1:161224201 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
4 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs3813627 | APOA2, TOMM40L | 0.00 | 0 | ||
| rs3813628 | TOMM40L | 0.00 | 0 | ||
| rs4073054 | NR1I3, TOMM40L | 0.00 | 0 | ||
| rs2307418 | NR1I3, TOMM40L | 0.00 | 0 |
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 5 |
| Valproic Acid | affects cotreatment, increases expression, affects expression, decreases expression | 5 |
| Acetaminophen | decreases expression | 3 |
| sodium arsenite | increases expression, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| trichostatin A | affects expression | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases abundance | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Lead | affects methylation | 1 |
| Ozone | increases abundance, affects cotreatment, decreases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.